Brief: Sensei Biotherapeutics posts Q2 basic EPS USD -0.31
Aug 3 (Reuters) - Sensei Biotherapeutics Q2 basic EPS USD -0.31. * Q2 operating expenses USD 10.177 million * Q2 income from operations USD -10.177 million * Q2 net income USD -9.386 million
Recent news on Faeth Therapeutics,
See all newsBrief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)